Geneva, April 20 -- International Clinical Trials Registry received information related to the study (KCT0011813) titled 'Population Pharmacokinetic Study of Cefepime in Healthy Adult Subjects' on April 3.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Non-RCT
Primary Sponsor: Hallym University Medical Center
Condition:
Factors influencing health status and contact with health services
Intervention:
Drug : Cefepime 1 g diluted in 100 mL of 0.9% normal saline will be administered as a single intravenous infusion over 30 minutes. The intervention will be performed once on the study day, followed by pharmacokinetic blood sampling an...